Home » Stocks » PTIX » Company

Protagenic Therapeutics, Inc. (PTIX)

Stock Price: $2.12 USD -0.11 (-4.93%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed
Protagenic Therapeutics, Inc.
Founded 1994
IPO Date Jan 5, 2016
Industry Biotechnology
Sector Healthcare

Contact Details

Address:149 Fifth Avenue
New York, NY 10010
United States
Phone 212 994 8200

Stock Information

Ticker Symbol PTIX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 1022899
CUSIP Number 71376K102
ISIN Number US74365N1037
Employer ID 06-1390025

Company Description

Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders.

Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses.

The company was founded in 2016 and is based in New York, New York.

Key Executives

Dr. Garo H. ArmenCo-Founder and Executive Chairman
Dr. Alexander Kenneth Arrow C.F.A., M.D., CFAChief Financial Officer and Secretary
Dr. Andrew SleeChief Operating Officer
Dr. Robert Benjamin SteinChief Medical Officer and Director
Dr. David A. LovejoyChief Scientific Officer, Scientific Founder and Scientific Advisor